318 related articles for article (PubMed ID: 12483537)
41. Characterization of novel inhibitors of cyclin-dependent kinases.
Kent LL; Hull-Campbell NE; Lau T; Wu JC; Thompson SA; Nori M
Biochem Biophys Res Commun; 1999 Jul; 260(3):768-74. PubMed ID: 10403840
[TBL] [Abstract][Full Text] [Related]
42. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
43. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
44. TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression.
Ko TC; Yu W; Sakai T; Sheng H; Shao J; Beauchamp RD; Thompson EA
Oncogene; 1998 Jul; 16(26):3445-54. PubMed ID: 9692552
[TBL] [Abstract][Full Text] [Related]
45. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
[TBL] [Abstract][Full Text] [Related]
47. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
48. Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53.
Kim AL; Athar M; Bickers DR; Gautier J
J Invest Dermatol; 2002 May; 118(5):818-24. PubMed ID: 11982759
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
[TBL] [Abstract][Full Text] [Related]
50. Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
Liu W; Sun M; Jiang J; Shen X; Sun Q; Liu W; Shen H; Gu J
Biochem Biophys Res Commun; 2004 Sep; 321(4):954-60. PubMed ID: 15358120
[TBL] [Abstract][Full Text] [Related]
51. Vitex rotundifolia Fruit Suppresses the Proliferation of Human Colorectal Cancer Cells through Down-regulation of Cyclin D1 and CDK4 via Proteasomal-Dependent Degradation and Transcriptional Inhibition.
Song HM; Park GH; Park SB; Kim HS; Son HJ; Um Y; Jeong JB
Am J Chin Med; 2018; 46(1):191-207. PubMed ID: 29298515
[TBL] [Abstract][Full Text] [Related]
52. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
53. Cdk4/cyclin D1 kinase, a universal and critical regulator of apoptosis.
Katayama K; Dobashi Y; Kitagawa M; Kawai M; Kadoya Y; Kameya T
Anticancer Res; 2003; 23(1A):235-43. PubMed ID: 12680219
[TBL] [Abstract][Full Text] [Related]
54. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
Das SK; Hashimoto T; Kanazawa K
Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
[TBL] [Abstract][Full Text] [Related]
55. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo.
Nelsen CJ; Rickheim DG; Timchenko NA; Stanley MW; Albrecht JH
Cancer Res; 2001 Dec; 61(23):8564-8. PubMed ID: 11731443
[TBL] [Abstract][Full Text] [Related]
56. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor and transforming growth factor-alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice.
Ramljak D; Jones AB; Diwan BA; Perantoni AO; Hochadel JF; Anderson LM
Cancer Res; 1998 Aug; 58(16):3590-7. PubMed ID: 9721866
[TBL] [Abstract][Full Text] [Related]
58. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
[TBL] [Abstract][Full Text] [Related]
59. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
[TBL] [Abstract][Full Text] [Related]
60. In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00.
Joshi KS; Rathos MJ; Joshi RD; Sivakumar M; Mascarenhas M; Kamble S; Lal B; Sharma S
Mol Cancer Ther; 2007 Mar; 6(3):918-25. PubMed ID: 17363486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]